NYU Langone Hospital - Long Island | Dialysis and Nephrology
Status
Conditions
Treatments
About
RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to allow for the on-going collection of safety and effectiveness data in subjects with uncontrolled hypertension despite the prescription of antihypertensive medications.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
300 participants in 1 patient group
Loading...
Central trial contact
Helen Reeve-Stoffer, PhD; Elizabeth Sheehan, MLIS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal